SCHEMBL190575

SCHEMBL190575

CC(C)(C)OC(=O)N(CCCOc1ccc(-c2cc(COC(N)=O)on2)cc1)NC(=O)O

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.40
RAB9A P51151 4/20 0.40
MAPT P10636 4/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
NPC1 O15118 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
CXCR1 P25024 2/20 0.39
CYP1A2 P05177 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
RET P07949 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
HTT P42858 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL189379 0.81 CA12 (0.51) SMN1; SMN2RAB9AMAPTL3MBTL1NPC1
SCHEMBL189579 0.78 SMN1; SMN2 (0.50) SMN1; SMN2RAB9AMAPTL3MBTL1NPC1
SCHEMBL189902 0.77 SMN1; SMN2 (0.48) SMN1; SMN2RAB9AMAPTL3MBTL1NPC1
SCHEMBL190352 0.77 SMPD1 (0.48) SMN1; SMN2RAB9AMAPTL3MBTL1NPC1
SCHEMBL189402 0.76 SMN1; SMN2 (0.47) SMN1; SMN2RAB9AMAPTL3MBTL1NPC1
SCHEMBL190629 0.76 SMN1; SMN2 (0.50) SMN1; SMN2RAB9AMAPTL3MBTL1NPC1
SCHEMBL190253 0.76 SMN1; SMN2 (0.49) SMN1; SMN2RAB9AMAPTL3MBTL1NPC1
SCHEMBL189578 0.76 SMN1; SMN2 (0.49) SMN1; SMN2RAB9AMAPTL3MBTL1NPC1
SCHEMBL189585 0.76 SMPD1 (0.47) SMN1; SMN2RAB9AMAPTL3MBTL1NPC1
SCHEMBL189986 0.75 XDH (0.49) SMN1; SMN2RAB9AMAPTL3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401263-A2 SUBSTITUTED AZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVES, AND METHOD FOR TREATING PARKINSON'S DISEASE USING THE SAME SK Biopharmaceuticals Co., Ltd. (KR) 2012-01-04 EP disclosed